Estimating Treatment Effect With Clinical Interpretation From a Comparative Clinical Trial With an End Point Subject to Competing Risks.

Pubmed ID: 29541747

Pubmed Central ID: PMC5875301

Journal: JAMA cardiology

Publication Date: April 1, 2018

Link: https://jamanetwork.com/journals/jamacardiology/articlepdf/2674719/jamacardiology_Zhao_2018_ld_180001.pdf?link_time=2025-03-14_01:32:39.743053

MeSH Terms: Humans, Cardiovascular Diseases, Randomized Controlled Trials as Topic, Data Interpretation, Statistical, Adrenergic beta-Antagonists, Treatment Outcome, Propanolamines, Mortality, Time Factors, Statistics as Topic

Grants: R21 AG049385, R01 HL136942

Authors: Zhao L, Tian L, Wei LJ, Claggett B, Solomon S, Kim DH, Pfeffer M

Cite As: Zhao L, Tian L, Claggett B, Pfeffer M, Kim DH, Solomon S, Wei LJ. Estimating Treatment Effect With Clinical Interpretation From a Comparative Clinical Trial With an End Point Subject to Competing Risks. JAMA Cardiol 2018 Apr 1;3(4):357-358.

Studies:

Abstract

This study explores using the restricted mean time lost to quantify treatment effects from cardiovascular therapy.